Reparixin Racemate

Modify Date: 2024-02-04 16:08:14

Reparixin Racemate Structure
Reparixin Racemate structure
Common Name Reparixin Racemate
CAS Number 957407-64-6 Molecular Weight 283.39
Density 1.1±0.1 g/cm3 Boiling Point N/A
Molecular Formula C14H21NO3S Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Reparixin Racemate


(Rac)-Reparixin is the inactive isomer of Reparixin (HY-15251), and can be used as an experimental control. Reparixin is a non-competitive allosteric inhibitor of the chemokine receptors CXCR1 and CXCR2 activation with IC50s of 1 and 100 nM, respectively.

 Names

Name n-[2-(4-isobutyl-phenyl)-propionyl]-methane sulfonamide
Synonym More Synonyms

 Reparixin Racemate Biological Activity

Description (Rac)-Reparixin is the inactive isomer of Reparixin (HY-15251), and can be used as an experimental control. Reparixin is a non-competitive allosteric inhibitor of the chemokine receptors CXCR1 and CXCR2 activation with IC50s of 1 and 100 nM, respectively.
Related Catalog
References

[1]. Sousa LF, et al. Blockade of CXCR1/2 chemokine receptors protects against brain damage in ischemic stroke in mice. Clinics (Sao Paulo). 2013;68(3):391-4.  

[2]. Bertini R, et al. Noncompetitive allosteric inhibitors of the inflammatory chemokine receptors CXCR1 and CXCR2: prevention of reperfusion injury. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11791-6.  

[3]. Krishnamurthy A, et al. Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss. Ann Rheum Dis. 2016 Apr;75(4):721-9.  

[4]. Crespo J, et al. Human Naive T Cells Express Functional CXCL8 and Promote Tumorigenesis. J Immunol. 2018 Jul 15;201(2):814-820.  

[5]. Moriconi A, et al. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2. J Med Chem. 2007 Aug 23;50(17):3984-4002.  

[6]. Bertini R, et al. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2non-competitive allosteric inhibitor. Br J Pharmacol. 2012 Jan;165(2):436-54.  

[7]. Kim HY, et al. Reparixin, an inhibitor of CXCR1 and CXCR2 receptor activation, attenuates blood pressure and hypertension-related mediators expression in spontaneously hypertensive rats. Biol Pharm Bull. 2011;34(1):120-7.  

 Chemical & Physical Properties

Density 1.1±0.1 g/cm3
Molecular Formula C14H21NO3S
Molecular Weight 283.39
Exact Mass 283.124207
LogP 2.66
Index of Refraction 1.525
Storage condition 2-8°C

 Synonyms

MFCD16621248
MFCD18633292
Benzeneacetamide, α-methyl-4-(2-methylpropyl)-N-(methylsulfonyl)-
reparixin
2-(4-Isobutylphenyl)-N-(methylsulfonyl)propanamide